Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06641128
What this trial is testing

The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)Methotrexate Induced NephrotoxicityMethotrexate Adverse Reaction
Tanta University 44
Testing effectiveness (Phase 2)Study completedNCT01185353
What this trial is testing

A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
Eli Lilly and Company 301
Early research (Phase 1)Looking for participantsNCT06801119
What this trial is testing

Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

Who this might be right for
Systemic Lupus ErythematosusSclerodermaRheumatoid Arthritis
Shenzhen MagicRNA Biotechnology Co., Ltd 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07636057
What this trial is testing

Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Sheikh Zayed Federal Postgraduate Medical Institute 100
Testing effectiveness (Phase 2)Study completedNCT00928512
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 237
Not applicableStudy completedNCT04574492
What this trial is testing

Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 413
Not applicableLooking for participantsNCT06108934
What this trial is testing

A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.

Who this might be right for
Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))
Stryker Australia Pty Ltd. 313
Testing effectiveness (Phase 2)Study completedNCT01181050
What this trial is testing

Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

Who this might be right for
InflammationRheumatoid Arthritis
Janssen Research & Development, LLC 63
Post-approval studies (Phase 4)Study completedNCT02831855
What this trial is testing

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Pfizer 694
Not applicableStudy completedNCT02797769
What this trial is testing

A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 48,950
Not applicableStudy completedNCT04356183
What this trial is testing

Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk

Who this might be right for
Rheumatoid Arthritis
Duke University 24
Large-scale testing (Phase 3)Study completedNCT00753454
What this trial is testing

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 168
Not applicableUnknownNCT06574594
What this trial is testing

Effect of MTX Discontinuation on Shingrix Response in RA

Who this might be right for
Rheumatoid Arthritis
Konkuk University Medical Center 110
Testing effectiveness (Phase 2)UnknownNCT04120831
What this trial is testing

TOLERA: Tolerance Enhancement in RA

Who this might be right for
Rheumatoid Arthritis
University of Erlangen-Nürnberg Medical School 20
Not applicableStudy completedNCT02964156
What this trial is testing

Effect of a Thin Customized Insole in RA

Who this might be right for
Rheumatoid Arthritis
Revmatismesykehuset AS 21
Post-approval studies (Phase 4)Study completedNCT01205854
What this trial is testing

Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial

Who this might be right for
Rheumatoid Arthritis
Espen A. Haavardsholm 238
Not applicableStudy completedNCT04667988
What this trial is testing

JAK2 Mutation May Predict Response and Guide First Line Treatment in Rheumatoid Arthritis

Who this might be right for
Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression
Mansoura University 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07377773
What this trial is testing

QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Qilu Pharmaceutical Co., Ltd. 180
Not applicableStudy completedNCT00195403
What this trial is testing

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

Who this might be right for
Rheumatoid Arthritis
Pfizer 1,014
Post-approval studies (Phase 4)UnknownNCT03895879
What this trial is testing

Use of Tocilizumab Drug Levels to Optimize Treatment in RA

Who this might be right for
Rheumatoid Arthritis
Reade Rheumatology Research Institute 98
Next Page